Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | SVP, Finance & Business Ops. | Jun 22, 2015 | Option Exercise | $78.87 | 56 | 4,417 | 24,446 | Jun 23, 2015, 10:33 AM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | SVP, Finance and Business Ops. | Mar 11, 2015 | Sale | $71.98 | 15,086 | 1,085,902 | 7,890 | Mar 13, 2015, 05:49 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Group Vice President, Finance | Dec 29, 2014 | Sale | $55.15 | 12,200 | 672,841 | 6,404 | Dec 30, 2014, 04:49 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Group Vice President, Finance | Jun 30, 2014 | Option Exercise | $54.89 | 112 | 6,148 | 304 | Jul 02, 2014, 05:56 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Group Vice President, Finance | Mar 12, 2014 | Sale | $57.03 | 15,340 | 874,916 | 7,862 | Mar 14, 2014, 04:07 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Group Vice President, Finance | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 192 | Jan 02, 2014, 07:07 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Jul 15, 2013 | Option Exercise | $8.95 | 3,019 | 27,027 | 2,524 | Jul 17, 2013, 04:21 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Jul 16, 2013 | Sale | $48.26 | 2,029 | 97,920 | 0 | Jul 17, 2013, 04:21 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Dec 19, 2012 | Sale | $23.44 | 8,000 | 187,505 | 4,000 | Dec 21, 2012, 03:45 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Oct 17, 2012 | Option Exercise | $25.49 | 8,000 | 203,920 | 4,000 | Oct 19, 2012, 05:10 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Sep 04, 2012 | Sale | $25.02 | 2,000 | 50,050 | 1,000 | Sep 06, 2012, 05:00 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Jun 01, 2012 | Sale | $18.34 | 2,000 | 36,683 | 1,000 | Jun 05, 2012, 05:10 PM | |
GEVA | SYNAGEVA BIOPHARMA CORP | Heberlig Chris | Vice President, Finance | Feb 27, 2012 | Option Exercise | $18.92 | 9,000 | 170,235 | 4,500 | Feb 29, 2012, 09:27 AM |